慢性阻塞性肺疾病合并衰弱的研究进展

doi:10.3969/j.issn.1003-9198.2021.08.022

摘要/Abstract

中图分类号:

R 563

高璐, 秦明照. 慢性阻塞性肺疾病合并衰弱的研究进展[J]. 实用老年医学, 2021, 35(8): 871-874.

[1] VOGELMEIER C F, CRINER G J, MARTINEA F J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report[J]. Am J Respir Crit Care Med, 2017, 195(5): 557-582.
[2] 中华医学会老年医学分会. 老年患者衰弱评估与干预中国专家共识[J]. 中华老年医学杂志, 2017, 36(3): 251-256.
[3] WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
[4] ZHOU M, WANG H, ZENG X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
[5] KOJIMA G. Frailty as a predictor of nursing home placement among community-dwelling older adults: a systematic review and meta-analysis[J]. J Geriatr Phys Ther, 2018, 41(1): 42-48.
[6] MA L, TANG Z, ZHANG L, et al. Prevalence of frailty and associated factors in the community-dwelling population of China[J]. J Am Geriatr Soc, 2018, 66(3): 559-564.
[7] LAHOUSSE L, ZIERE G, VERLINDEN V J A, et al. Risk of frailty in elderly with COPD: a population-based study[J]. J Gerontol A Biol Sci Med Sci, 2016, 71(5): 689-695.
[8] MARENGONI A, VETRANO DL, MANES-GRAVINA E, et al. The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies[J]. Chest, 2018, 154(1): 21-40.
[9] 夏魁, 朱纯儒, 孙伟, 等. 老年慢性阻塞性肺病患者衰弱现状调查及危险因素分析[J]. 中国临床保健杂志, 2019, 22(2): 220-223.
[10] MADDOCKS M, KON S S, CANAVAN J L, et al. Physical frailty and pulmonary rehabilitation in COPD: A prospective cohort study[J]. Thorax, 2016, 71(11): 988-995.
[11] BERNABEU-MORA R, GARCIA-GUILLAMON G, VALERA-NOVELLA E, et al. Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: A longitudinal study[J]. Ther Adv Respir Dis 2017, 11(10): 383-392.
[12] GALIZIA G, CACCIATORE F, TESTA G, et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease[J]. Aging Clin Exp Res, 20ll, 23(2): 118-125.
[13] VAZ FRAGOSO C A, ENRIGHT P L, MCAVAY G, et al. Frailty and respiratory impairment in older persons[J]. Am J Med, 2012, 125(1): 79-86.
[14] LEE J S, AUYEUNG T W, LEUNG J, et al. Transitions in frailty states among community-living older adults and their associated factors[J]. J Am Med Dir Assoc, 2014, 15(4): 281-286.
[15] ESPINOZA S E, HAZUDA H P. Frailty prevalence and neighborhood residence in older Mexican Americans: the San Antonio longitudinal study of aging[J]. J Am Geriatr Soc, 2015, 63(1): 106-111.
[16] GERSHON A S, DOLMAGE T E, STEPHNSON A, et al. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review[J]. COPD, 2012, 9(3): 216-226.
[17] THOMSEN M, INGEBRIGTSEN T S, MARROTT J L, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease[J]. JAMA, 2013, 309(22): 2353-2361.
[18] GIULIA B, CATERINA T, SARA C, et al. Inflammation and sarcopenia: A systematic review and meta-analysis[J]. Maturitas, 2017, 96(2): 10-15.
[19] GIFFORD J R, TRINITY J D, LAYEC G, et al. Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration[J]. J Appl Physiol, 2015, 119(8): 882-888.
[20] MALTAIS F, DECTAMER M, CASABURI R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease[J]. Am J Respir CritCare Med, 2014, 189(9): e15-62.
[21] BOUKHENOUNA S, WILSON M A, BAHMED K, et al. Reactive oxygen species in chronic obstructive pulmonary disease[J]. Oxid Med Cell Longev, 2018, 2018:5730395.
[22] JAITOVICH A, ANGULO M, LECUONA E, et al. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), Fox03aprotein, and muscle-specific ring finger protein 1 (MuRF1)[J]. J Biol Chem, 2015, 290(14): 9183-9194.
[23] JU C R, ZHANG J H, CHEN M, et al. Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease[J]. Biomarkers, 2017, 22(3/4): 246-252.
[24] VANDE BOOL C, GOSKER H R, VANDEN BORST B, et al. Muscle quality is more impaired in sarcopenic patients with chronic obstructive pulmonary disease[J]. J Am Med DirAssoc, 2016, 17(5): 415-420.
[25] ANDREW C, ZAKI H S.Frailty and the endocrine system[J]. Lancet Diabetes Endocrinol, 2018, 6(9): 743-752.
[26] IQBAL J, DENVIR M, GUNN J. Frailty assessment in elderly people[J]. Lancet, 2013, 381(9882): 1985-1986.
[27] HIRAI K, TANAKA A, HOMMA T. Comparison of three frailty models and a sarcopenia model in elderly patients with chronic obstructive pulmonary disease[J]. Geriatr Gerontol Int, 2019, 19(9): 896-901.
[28] 中国老年医学学会呼吸病学分会慢性阻塞性肺疾病学组. 中国老年慢性阻塞性肺疾病临床诊治实践指南[J]. 中华结核和呼吸杂志, 2020, 43(2): 100-119.
[29] TANNER A, VASSALLO M, KWAN J. The pulmonary rehabilitation regimen: a treatment for frailty and ‘inflammaging’? [J]. Br J Hosp Med (Lond), 2018, 79(8): 432-437.
[30] DE LABRA C, GUIMARAES-PINHEIRO C, MASEDA A, et al. Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials[J]. BMC Geriatr, 2015, 15(1): 154.
[31] ABD El-KADER S M, AL-JIFFRI O H, AL-SHREEF F M. Plasma inflammatory biomarkers response to aerobic versus resisted exercise training for chronic obstructive pulmonary disease patients[J]. Afr Health Sci, 2016, 16(2): 507-515.
[32] BLAKE H. Physical activity and exercise in the treatment of depression[J]. Front Psychiatry, 2012, 7(3): 106.
[33] ATTWELL L, VASSALLO M. Responses to pulmonary rehabilitation in older people with physical frailty, sarcopenia and chronic lung disease[J]. Geriatrics, 2017, 2(1): 9.
[34] FERREIRA I M, BROOKS D, LACASSE Y, et al. Nutritional supplementation in stable chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2012, 12(12): CD000998.
[35] VANDE BOOL C, RRTTEN E P A, VAN HELVOOR T, et al. A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD[J]. J Cachexia Sarcopenia Muscle, 2017, 8(5): 748-758.
[36] KOKTURK N, BAHA A, OH Y M, et al. Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? A comprehensive review for pulmonologists[J]. Clin Respir J, 2018, 12(2): 382-397.

慢性阻塞性肺疾病合并衰弱的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	周赟, 张影影, 高妍芬. 肺力咳合剂联合噻托溴铵粉雾剂在高龄慢性阻塞性肺疾病病人中的效果观察[J]. 实用老年医学, 2024, 38(10): 1011-1015.
[2]	雷万锋, 马秀红. 老年COPD急性加重期病人血清IL-33/sST2轴表达及其对预后的预测价值[J]. 实用老年医学, 2024, 38(10): 1044-1048.
[3]	徐金燕, 夏聪聪, 杨红美. 老年脑卒中肺部感染风险预测模型的建立及验证[J]. 实用老年医学, 2024, 38(5): 452-437.
[4]	彭泽通, 张尧, 刘斌. 贫血对老年社区获得性肺炎死亡的影响分析[J]. 实用老年医学, 2024, 38(3): 260-264.
[5]	苏雪姣, 刘月, 孙蜀宁. 高龄新型冠状病毒感染老年人外周血液学指标与预后的相关性[J]. 实用老年医学, 2024, 38(3): 291-292.
[6]	张杰斯, 黎艳聪, 卢钻芬, 李明标. 黏液玫瑰单胞菌致COPD急性加重1例及文献分析[J]. 实用老年医学, 2024, 38(3): 322-324.
[7]	王瑞萍, 张妮. COPD病人一氧化碳弥散量与运动耐力、呼吸困难及通气效率的相关性研究[J]. 实用老年医学, 2024, 38(2): 141-144.
[8]	姬泽萱, 冯平, 李峰, 项保利, 冯改霞. 老年男性COPD合并骨质疏松病人睾酮及FGF23、MMP-9水平的变化[J]. 实用老年医学, 2024, 38(2): 176-178.
[9]	周柳青, 周计雪, 柳毅. 抑郁症病人抗抑郁药物治疗中2次发生肺栓塞:2例报道[J]. 实用老年医学, 2024, 38(2): 203-205.
[10]	秦克, 李同林, 华俊萍, 江美芳. 老年COPD稳定期病人经鼻高流量湿化氧疗血清颗粒蛋白前体表达水平及意义[J]. 实用老年医学, 2023, 37(12): 1215-1218.
[11]	李娜, 叶莹, 王鸿林, 周秋红. 老年新型冠状病毒感染病人营养支持的研究进展[J]. 实用老年医学, 2023, 37(11): 1081-1075.
[12]	郭佳丽, 黄淳, 陶子荣, 彭伶丽. 老年新型冠状病毒感染病人俯卧位通气管理的最佳证据总结[J]. 实用老年医学, 2023, 37(11): 1086-1091.
[13]	王雪敬, 邓宝凤, 罗昌春, 赵玉荣, 张爱军, 刘海荣, 赵艳梅. 新型冠状病毒感染期间远程探视系统在老年肿瘤住院病人中的应用[J]. 实用老年医学, 2023, 37(11): 1095-1098.
[14]	陈秋羽, 王展展, 李春华. 肠道菌群相关短链脂肪酸在COPD发病机制中的作用研究进展[J]. 实用老年医学, 2023, 37(11): 1166-1169.
[15]	王世福, 欧宗兴, 符沙沙. 老年COPD相关肺动脉高压病人血管活性肠肽水平及其与高凝、低氧状态和血管内皮功能的相关性[J]. 实用老年医学, 2023, 37(9): 907-910.